ICMI 2015

OR.3 Lymph Borne CD8α+ DCs Are Uniquely Able to Cross-Prime CD8+ T Cells with Intestinal Epithelial Cell-Derived Antigen

Wednesday, July 15, 2015: 11:15 AM
Hall Berlin B, Ground Floor (Maritim Hotel)
Vuk Cerovic , RWTH Aachen University, Aachen, Germany
Stephanie Houston , The University of Glasgow, Glasgow, United Kingdom
Jessica Westlund , Department of Medical Microbiology and Immunology, University of Gothenburg, Gothenburg, Sweden
Lotta Utriainen , University of Glasgow, Glasgow, United Kingdom
Charlotte Scott , VIB, Ghent University, Ghent, Belgium
Calum Bain , MRC Centre for Inflammation Research, University of Edinburgh, Edinburgh, United Kingdom
Thorsten Joeris, PhD , Lund University - Department of Experimental Medical Science - Immunology Section, Lund, Sweden
William Agace, PhD , Lund University - Department of Experimental Medical Science - Immunology Section, Lund, Sweden
Richard Kroczek , Robert Koch Institute, Berlin, Germany
Allan Mowat, MD, PhD , University of Glasgow, Glasgow, Scotland, SCOTLAND
Ulf Yrlid , Department of Medical Microbiology and Immunology, University of Gothenburg, Gothenburg, Sweden
Simon Milling, PhD , University of Glasgow, Glasgow, United Kingdom
Cross-presentation of cellular antigen is crucial for priming CD8+ T cells, and generating immunity to intracellular pathogens- particularly viruses. It is unclear which intestinal phagocytes perform this function in vivo. We therefore examined dendritic cells (DCs) from intestinal lymph of IFABP-tOVA 232-4 mice, which express ovalbumin in small intestinal epithelial cells (IECs). Among lymph DCs (LDCs), only CD103+ CD11b- CD8α+ DCs cross-present IEC-derived ovalbumin to CD8+ OT-I T cells. Similarly, in the mesenteric lymph nodes (MLN), cross-presentation of IEC-ovalbumin was limited to the CD11c+ MHCIIhi CD8α+ migratory DCs, but absent from all other subsets, including the resident CD8αhi DCs. Crucially, delivery of purified CD8α+ LDCs, but not other LDC subsets, into the MLN subcapsular lymphatic sinus induced proliferation of ovalbumin-specific, gut-tropic CD8+ T cells in vivo. Finally, in 232-4 mice treated with R848, CD8α+ LDCs were uniquely able to cross-prime IFN-γ-producing CD8+ T cells and drive their migration to the intestine. These results clearly demonstrate that migrating CD8α+ intestinal DCs are indispensable for cross-presentation of cellular antigen and, in conditions of inflammation, for the initial differentiation of effector CD8+ T cells. They may therefore represent an important target for the development of anti-viral vaccinations.